Financials Craven House Capital Plc
Equities
CRV
GB00BD4FQ360
Investment Management & Fund Operators
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2 USD | 0.00% | 0.00% | +33.33% |
Feb. 28 | EARNINGS: Hutchmed revenue surges, Craven House's loss widens | AN |
Feb. 28 | Craven House Capital Plc Reports Earnings Results for the Half Year Ended November 30, 2023 | CI |
Valuation
Fiscal Period: May | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 11.5 | 8.122 | 7.534 | 3.284 | 0.9273 | 0.6568 |
Enterprise Value (EV) 1 | 12.08 | 8.876 | 7.528 | 4.268 | 0.9263 | 0.6528 |
P/E ratio | -29.1 x | -4.49 x | -0.43 x | -1.35 x | -3.93 x | -0.12 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | -54.3 x | 14.8 x | -2.78 x | -14.8 x | -5.67 x | -5.49 x |
FCF Yield | -1.84% | 6.77% | -36% | -6.77% | -17.7% | -18.2% |
Price to Book | 0.46 x | 0.35 x | 0.97 x | 0.61 x | 0.18 x | -1.71 x |
Nbr of stocks (in thousands) | 2,499 | 2,499 | 3,864 | 3,864 | 3,864 | 3,864 |
Reference price 2 | 4.600 | 3.250 | 1.950 | 0.8500 | 0.2400 | 0.1700 |
Announcement Date | 11/28/18 | 11/28/19 | 12/16/20 | 12/1/21 | 12/2/22 | 11/28/23 |
Income Statement Evolution (Annual data)
Fiscal Period: May | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - |
EBIT 1 | -0.985 | -2.284 | 0.719 | -0.208 | -0.18 | -0.186 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -0.395 | -1.809 | -13.19 | -2.431 | -0.236 | -5.515 |
Net income 1 | -0.395 | -1.809 | -13.19 | -2.431 | -0.236 | -5.515 |
Net margin | - | - | - | - | - | - |
EPS 2 | -0.1581 | -0.7239 | -4.565 | -0.6292 | -0.0611 | -1.427 |
Free Cash Flow 1 | -0.2226 | 0.6005 | -2.712 | -0.289 | -0.1635 | -0.1189 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 11/28/18 | 11/28/19 | 12/16/20 | 12/1/21 | 12/2/22 | 11/28/23 |
Balance Sheet Analysis
Fiscal Period: May | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 0.59 | 0.75 | - | 0.98 | - | - |
Net Cash position 1 | - | - | 0.01 | - | 0 | 0 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -0.22 | 0.6 | -2.71 | -0.29 | -0.16 | -0.12 |
ROE (net income / shareholders' equity) | -1.58% | -7.55% | -85.5% | -36.9% | -4.5% | -232% |
ROA (Net income/ Total Assets) | -2.25% | -5.06% | 2.47% | -1.79% | -1.75% | -3.05% |
Assets 1 | 17.52 | 35.79 | -534.1 | 135.5 | 13.52 | 180.8 |
Book Value Per Share 2 | 9.950 | 9.230 | 2.020 | 1.390 | 1.330 | -0.1000 |
Cash Flow per Share 2 | 0.0900 | 0.0200 | 0 | 0 | 0 | 0 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 11/28/18 | 11/28/19 | 12/16/20 | 12/1/21 | 12/2/22 | 11/28/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+33.33% | 773K | |
-5.90% | 114B | |
-5.79% | 87.22B | |
+9.71% | 64.53B | |
+20.26% | 62.28B | |
+9.51% | 42.63B | |
+10.30% | 41.73B | |
+19.41% | 34.99B | |
+3.54% | 24.9B | |
-3.96% | 22.41B |
- Stock Market
- Equities
- CRV Stock
- Financials Craven House Capital Plc